Company / Free Cash Flow
enGene Holdings Inc. Free Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$100.7M
FY2025
5-year range
-$100.7M / -$17.7M
FY2022-FY2025
Trend
-104.7%
vs FY2024
Sector context
#110 of 195
Health Care
What the data says
At -$101M, enGene Holdings Inc.'s free cash flow ranks #110 of 195 in the Health Care sector. Free Cash Flow has declined for 3 consecutive years, from -$18M in FY2022 to -$101M in FY2025.
Based on SEC 10-K filings.
-$101M in FY2025.
Declined from -$25M to -$101M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 195 in Health CareTop 56% of 195This company -$100.7M Sector average $465.6M
▼
-121.6% below sector average
Key checks
Key Insights
- enGene Holdings Inc.'s free cash flow has declined for 3 consecutive years.
- In FY2025, free cash flow decreased 104.7% year-over-year.
- Ranks #110 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$100.7M | -104.7% |
| FY2024 | -$49.2M | -96.3% |
| FY2023 | -$25.1M | -41.2% |
| FY2022 | -$17.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026